TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons

被引:83
作者
Kato, K
Hayako, H
Ishihara, Y
Marui, S
Iwane, M
Miyamoto, M
机构
[1] Takeda Chem Ind Ltd, Pharma Res Labs 5, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
[2] Takeda Chem Ind Ltd, Med Chem Labs, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
[3] Takeda Chem Ind Ltd, Dept Strateg Dev, Div Pharmaceut Res, Chuo Ku, Osaka 5408645, Japan
关键词
TAK-147; acetylcholinesterase inhibitor; NGF; choline acetyltransferase; sigma ligand; donepezil; septal neurons;
D O I
10.1016/S0304-3940(98)00943-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TAK-147, a potent acetylcholinesterase (AChE) inhibitor, potentiated choline acetyltransferase (ChAT) activity in cultured rat septal cholinergic neurons in a concentration-dependent manner with an EC50 value of 4.47 nM. Donepezil, another potent AChE inhibitor, also increased ChAT activity although its potency was less than that of TAK-147. Other AChE inhibitors (rivastigmine, tacrine, physostigmine and neostigmine) showed no effect. The effects of TAK-147 were greater in the presence of NGF, suggesting a synergistic action of TAK-147 and NGF. TAK-147 and donepezil showed high affinity for a receptors, whereas tacrine and physostigmine did not. Haloperidol and ifenprodil, high-affinity a ligands, potently enhanced ChAT activity in the septal neurons. These results suggest that TAK-147 may have neurotrophic activity on central cholinergic neurons, not via AChE inhibition but possibly via an effect on sigma receptors. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 19 条
[1]   BIOCHEMICAL AND ELECTROPHYSIOLOGICAL PROPERTIES OF SR 57746A, A NEW, POTENT 5-HT(1A) RECEPTOR AGONIST [J].
BACHY, A ;
STEINBERG, R ;
SANTUCCI, V ;
FOURNIER, M ;
LANDI, M ;
HAMON, M ;
MANARA, L ;
KEANE, PE ;
SOUBRIE, P ;
LEFUR, G .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (09) :487-497
[2]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[3]   ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION [J].
COYLE, JT ;
PRICE, DL ;
DELONG, MR .
SCIENCE, 1983, 219 (4589) :1184-1190
[4]  
DAVIES P, 1976, LANCET, V2, P1403
[5]   SIGMA-RECEPTOR-MEDIATED NEUROPROTECTION AGAINST GLUTAMATE TOXICITY IN PRIMARY RAT NEURONAL CULTURES [J].
DECOSTER, MA ;
KLETTE, KL ;
KNIGHT, ES ;
TORTELLA, FC .
BRAIN RESEARCH, 1995, 671 (01) :45-53
[6]   RAPID RADIOCHEMICAL METHOD FOR DETERMINATION OF CHOLINE-ACETYLTRANSFERASE [J].
FONNUM, F .
JOURNAL OF NEUROCHEMISTRY, 1975, 24 (02) :407-409
[7]   Purification, molecular cloning, and expression of the mammalian sigma(1)-binding site [J].
Hanner, M ;
Moebius, FF ;
Flandorfer, A ;
Knaus, HG ;
Striessnig, J ;
Kempner, E ;
Glossmann, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :8072-8077
[8]   DIFFERENTIAL-EFFECTS OF NERVE-GROWTH FACTOR AND GLIOMA-CONDITIONED MEDIUM ON NEURONS CULTURED FROM VARIOUS REGIONS OF FETAL-RAT CENTRAL-NERVOUS-SYSTEM [J].
HATANAKA, H ;
TSUKUI, H .
DEVELOPMENTAL BRAIN RESEARCH, 1986, 30 (01) :47-56
[9]  
HEFTI F, 1986, J NEUROSCI, V6, P2155
[10]  
Hirai K, 1997, J PHARMACOL EXP THER, V280, P1261